Last reviewed · How we verify
Botulinum Toxin commonly known as BOTOX®
Botulinum Toxin commonly known as BOTOX® is a Neurotoxin; acetylcholine release inhibitor Small molecule drug developed by NYU Langone Health. It is currently in Phase 3 development for Cervical dystonia, Blepharospasm, Strabismus. Also known as: BOTOX®, Saline.
Botulinum toxin blocks the release of acetylcholine at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.
Botulinum toxin blocks the release of acetylcholine at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis. Used for Cervical dystonia, Blepharospasm, Strabismus.
At a glance
| Generic name | Botulinum Toxin commonly known as BOTOX® |
|---|---|
| Also known as | BOTOX®, Saline |
| Sponsor | NYU Langone Health |
| Drug class | Neurotoxin; acetylcholine release inhibitor |
| Target | SNARE complex proteins (SNAP-25, VAMP, syntaxin) |
| Modality | Small molecule |
| Therapeutic area | Neurology; Aesthetics; Pain Management |
| Phase | Phase 3 |
Mechanism of action
Botulinum toxin is a neurotoxin that irreversibly cleaves proteins required for acetylcholine vesicle fusion and release at the presynaptic terminal. This prevents neuromuscular transmission, resulting in flaccid paralysis of the targeted muscle. The effect is temporary, lasting 3-4 months, as the body gradually regenerates the cleaved proteins and forms new neuromuscular junctions.
Approved indications
- Cervical dystonia
- Blepharospasm
- Strabismus
- Chronic migraine
- Hyperhidrosis
- Spasticity
- Facial wrinkles and dynamic expression lines
Common side effects
- Headache
- Neck pain
- Muscle weakness
- Injection site pain
- Flu-like symptoms
- Eyelid ptosis
- Diplopia
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Botulinum Toxin commonly known as BOTOX® CI brief — competitive landscape report
- Botulinum Toxin commonly known as BOTOX® updates RSS · CI watch RSS
- NYU Langone Health portfolio CI
Frequently asked questions about Botulinum Toxin commonly known as BOTOX®
What is Botulinum Toxin commonly known as BOTOX®?
How does Botulinum Toxin commonly known as BOTOX® work?
What is Botulinum Toxin commonly known as BOTOX® used for?
Who makes Botulinum Toxin commonly known as BOTOX®?
Is Botulinum Toxin commonly known as BOTOX® also known as anything else?
What drug class is Botulinum Toxin commonly known as BOTOX® in?
What development phase is Botulinum Toxin commonly known as BOTOX® in?
What are the side effects of Botulinum Toxin commonly known as BOTOX®?
What does Botulinum Toxin commonly known as BOTOX® target?
Related
- Drug class: All Neurotoxin; acetylcholine release inhibitor drugs
- Target: All drugs targeting SNARE complex proteins (SNAP-25, VAMP, syntaxin)
- Manufacturer: NYU Langone Health — full pipeline
- Therapeutic area: All drugs in Neurology; Aesthetics; Pain Management
- Indication: Drugs for Cervical dystonia
- Indication: Drugs for Blepharospasm
- Indication: Drugs for Strabismus
- Also known as: BOTOX®, Saline